News
Search EMA's news announcements
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours. To fetch data from this website via automated systems, please use our JSON data files.
Patients can locate trials for potential enrolment in their area
Positive opinion for extension of indication brings disease-modifying treatment to all cystic fibrosis patients with modulator responsive mutations
Four new medicines recommended for approval; another 16 medicines recommended for extension of their therapeutic indications
Vyjuvek expected to bring substantial therapeutic benefits and improve quality of life for patients with ultra-rare genetic skin disorder
Eco-Management and Audit Scheme (EMAS) certificate is a mark of environmental excellence in the EU
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
Clinical Trials Information System now supports submission, assessment and oversight of all trials in the EU
EMA opinion for ivermectin and albendazole supports global efforts to eliminate widespread infections
The review of Vimkunya was expedited because of public health interest